TY - JOUR
T1 - Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006
AU - Krum, Henry
AU - Jelinek, Michael V.
AU - Stewart, Simon
AU - Sindone, Andrew
AU - Atherton, John J.
AU - Hawkes, Anna L.
AU - Amerena, John
AU - Beltrame, John
AU - Burrell, Louise
AU - Campbell, Duncan
AU - Davidson, Patricia
AU - DePasquale, Carmine
AU - Doughty, Rob
AU - Esmore, Donald
AU - Feneley, Michael
AU - Galbraith, Andrew
AU - Gilbert, Richard
AU - Goble, Alan
AU - Hare, David
AU - Horowitz, John
AU - Kalman, John
AU - Kaye, David
AU - Keogh, Ann
AU - Larbalestier, Robert
AU - Leitch, James
AU - McDonald, Peter
AU - Marwick, Tom
AU - McGuire, Mark
AU - Meyers, Deborah
AU - Mottram, Phil
AU - Pollock, Carol
AU - Walsh, Warren
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2006/11/20
Y1 - 2006/11/20
N2 - • Chronic heart failure (CHF) is found in 1.5/6-2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged, ≥65 years. • CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years). • Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two-thirds of cases) and idiopathic dilated cardiomyopathy (around 5%-10% of cases). • Diagnosis is based on clinical features, chest x-ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B-type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms. • Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival.
AB - • Chronic heart failure (CHF) is found in 1.5/6-2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged, ≥65 years. • CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years). • Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two-thirds of cases) and idiopathic dilated cardiomyopathy (around 5%-10% of cases). • Diagnosis is based on clinical features, chest x-ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B-type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms. • Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival.
UR - https://www.scopus.com/pages/publications/33751416414
UR - https://www.scopus.com/pages/publications/33751416414#tab=citedBy
U2 - 10.5694/j.1326-5377.2006.tb00690.x
DO - 10.5694/j.1326-5377.2006.tb00690.x
M3 - Article
C2 - 17115967
AN - SCOPUS:33751416414
SN - 0025-729X
VL - 185
SP - 549
EP - 556
JO - Medical Journal of Australia
JF - Medical Journal of Australia
IS - 10
ER -